Ledger.Open graph →
SEC Form D · filed December 2, 2019

ELIXIRGEN THERAPEUTICS, INC

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BALTIMORE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Maiko Katadae · Baltimore, MDDirectorMinoru Ko · Baltimore, MDDirectorNaonori Kurokawa · Baltimore, MDDirectorAkihiro Ko · Baltimore, MDExec · DirectorTimothy L. Elliott · St. Louis, MOExec · DirectorMichael R. Farris · St. Louis, MODirectorRandall J. Combs · St. Louis, MODirectorLeah M. Hodges · Garibaldi Highlands, British Columbia, CanadaDirectorLijun Lin · Shanghai, IsraelExec · DirectorJeffrey B. Alpert · Leawood, KSDirectorMaximilian Coreth · Alta, UTDirectorChika Watanabe · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗